2023 Fall Conference - Speakers


Jennifer Granick, DVM, PhD, DACVIM (SAIM)

Dr. Jennifer Granick is an associate professor of small animal internal medicine at the University of Minnesota College of Veterinary Medicine. Her clinical interests include infectious and zoonotic diseases, including antimicrobial resistant infections. Her research focuses on clinical antibiotic use and antimicrobial stewardship. She is Co-director of the Antimicrobial Resistance and Stewardship Initiative (ARSI) at the University of Minnesota and the Companion Animal Veterinary Surveillance Network. She chairs the University of Minnesota Veterinary Medical Center’s Antimicrobial Stewardship Committee. Dr. Granick also serves on the American Veterinary Medical Association's Committee on Antimicrobials and the World Small Animal Veterinary Association's Therapeutic Guidelines Group.


Kelly Makielski, DVM, MS, DACVIM (SAIM)

Kelly Makielski is an Assistant Professor of Small Animal Internal Medicine at the University of Minnesota College of Veterinary Medicine. Dr. Makielski completed veterinary school at the University of Wisconsin-Madison, graduating in 2010. She then completed a rotating internship at Angell Animal Medical Center, followed by a specialty internship and residency in Small Animal Internal Medicine at Iowa State University. Dr. Makielski completed a Master of Science degree during her residency, focused on veterinary hematology, specifically the role of platelets in bleeding and thrombosis. Following board certification in Small Animal Internal Medicine, Dr. Makielski completed a post-doctoral fellowship in the Comparative Oncology Lab at the University of Minnesota under Dr. Jaime Modiano, where she investigated the immune response induced by immunotherapy in canine osteosarcoma. Dr. Makielski joined the Small Animal Internal Medicine department at the University of Minnesota in 2022. Her research interests include exosome biology and translational research using animal models to further our understanding of human diseases. Dr. Makielski recently received an NIH K01 award to investigate exosomal gene signatures associated with metastatic propensity in pediatric osteosarcoma.